Stay updated on TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.

Latest updates to the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page
- Check6 days agoChange DetectedThe page revision/version label was updated from **v3.5.2** to **v3.5.3**, indicating a site update rather than any modification to the ClinicalTrials.gov study record content.SummaryDifference0.1%

- Check13 days agoChange DetectedAdded Revision: v3.5.2. Removed mentions of 'Multiple myeloma', 'related topics:', 'MedlinePlus Genetics', and 'Revision: v3.5.0'.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedAdded related topics for 'Multiple myeloma' and 'MedlinePlus Genetics', and updated the site revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check56 days agoChange DetectedRevision label changed from v3.4.2 to v3.4.3. This appears to be a minor backend or display update with no observable changes to the study details or page content.SummaryDifference0.1%

- Check63 days agoChange DetectedRemoved mentions of the disease name 'Multiple Myeloma' and the related topic 'MedlinePlus Genetics' from the page content.SummaryDifference0.2%

- Check70 days agoChange DetectedAdded Related topics: Multiple myeloma and MedlinePlus Genetics to the page.SummaryDifference0.2%

Stay in the know with updates to TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.